Nuclear localization of ABCG2 has previously been reported in glioblastoma multiforme cells [43] and also in lung cancer cells [44], where decreased ABCG2 expression was connected with down-regulation of E-cadherin and enhanced motility of cancer cells. This evidence concerns the gene CDH1 and lung carcinoma.